Coeliac disease: Dissecting a complex inflammatory disorder

Nature Reviews Immunology

Volumn 2, Issue 9, 2002, Pages 647-655

  Sollid, Ludvig M ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTEN; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSGLUTAMINASE 2;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CELIAC DISEASE; CHRONIC INFLAMMATION; ENVIRONMENTAL FACTOR; ENZYME THERAPY; GENETIC DISORDER; GLUTEN FREE DIET; HLA GENE; HLA SYSTEM; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INFLAMMATION; INTESTINE CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENICS; AMINO ACID SEQUENCE; CD4+ T LYMPHOCYTE; CHEMISTRY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; SMALL INTESTINE;

AMINO ACID SEQUENCE; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; EPITOPES; GENETIC PREDISPOSITION TO DISEASE; GLUTEN; GTP-BINDING PROTEINS; HLA-DQ ANTIGENS; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTESTINAL MUCOSA; INTESTINE, SMALL; MOLECULAR SEQUENCE DATA; TRANSGLUTAMINASES;

EID: 0036715684     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri885     Document Type: Review

References (101)

1. Fasano, A. & Catassi, C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120, 635-651 (2001).
2. Corrao, G. et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358, 356-361 (2001).
3. Mäkl, M. in Coelfac Disease (ed. Howdle, P. D.) 231-249 (Baillière Tindall, London, 1995).
4. Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med. 3, 797-801 (1997). This paper identifies tissue transglutaminase (TG2) as the autoantigen that is recognized by coeliac-disease-specific anti-endomysial antibodies.
5. Sulkanen, S. et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115, 1322-1328 (1998).
6. Risch, N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet 40, 1-14 (1987).
7. Petronzelli, F. et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann. Hum. Genet. 61, 307-317 (1997).
8. Bevan, S. et al. Contribution of the MHC region to the familial risk of coeliac disease. J. Med Genet. 36, 687-690 (1999).
9. Greco, L. et al. The first large population-based twin study of coeliac disease. Gut 50, 624-628 (2002).
10. Keuning, J. J., Pena, A. S., van Leeuwen, A., van Hooff, J. P. & van Rood, J. J. HLA-DW3 associated with coeliac disease. Lancet 1, 506-508 (1976).
11. Ek, J., Albrechtsen, D., Solheim, B. G. & Thorsby, E. Strong association between the HLA-Dw3-related B-cell alloantigen DRw3 and coeliac disease. Scand. J. Gastroenterol. 13, 229-233 (1978).
12. Mearin, M. L. et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 24, 532-537 (1983).
13. Trabace, S. et al. HLA-ABC and DR antigens in celiac disease. A study in a pediatric Italian population. Vox Sang. 48, 102-106 (1984).
14. Tosi, R. et al. Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin. Immunol. Immunopathol. 28, 395-404 (1983).
15. Sollid, L. M. et al. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J. Exp. Med. 169, 345-350 (1989). This paper identifies HLA-DQ2 encoded in cis or in trans by the DQA1*05 and DQB1*02 alleles as the primary disease-susceptibility molecule in coeliac disease.
16. Sollid, L. M. Molecular basis of celiac disease Annu. Rev. Immunol. 18, 53-81 (2000).
17. Djilali-Saiah, I. et al. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 43, 187-189 (1998).
18. Holopainen, P. et al. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study. Tissue Antigens 53, 470-475 (1999).
19. Naluai, A. T. et al. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type-1 diabetes and other chronic inflammatory disorders. Tissue Antigens 56, 350-355 (2000).
20. King, A. L. et al. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families. J. Med. Genet. 39, 51-54 (2002).
21. Popat, S. et al. Analysis of the CTLA4 gene in Swedish coeliac disease patients. Scand. J. Gastroenterol. 37, 28-31 (2002).
22. Zhong, F. et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nature Genet. 14, 329-333 (1996).
23. Greco, L. et al. Genome search in celiac disease. Am. J. Hum. Genet. 62, 669-675 (1998). The first study to provide strong evidence that there is a coeliac-disease risk factor on chromosome 5q.
24. Houlston, R. S. et al. Linkage analysis of candidate regions for coeliac disease genes. Hum. Mol. Genet. 6, 1335-1339 (1997).
25. King, A. L. et al. A genome-wide family-based linkage study of coeliac disease. Ann. Hum. Genet. 64, 479-490 (2000).
26. Greco, L. et al. Existence of a genetic risk factor on chromosome 5q in Italian celiac-disease families. Ann. Hum. Genet. 65, 35-41 (2001).
27. Holopainen, P. et al. Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut 48, 696-701 (2001).
28. Naluai, T. A. et al. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur. J. Hum. Genet. 9, 938-944 (2001).
29. Liu, J. et al. Genome-wide linkage analysis of celiac disease in Finnish families. Am J. Hum. Genet. 70, 51-59 (2002).
30. Rioux, J. D. et al. Genetic vanation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genet. 29, 223-228 (2001).
31. Guler, M. L. et al. Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism, J. Immunol. 162, 1339-1347 (1999).
32. Morahan, G. et al. Linkage disequilibrium of a type-1 diabetes susceptibility locus with a regulatory IL12B allele. Nature Genet. 27, 218-221 (2001).
33. McIntire, J. J. et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nature Immunol. 2, 1109-1116 (2001).
34. Louka, A. S. et al. The IL12B gene does not confer susceptibility to coeliac disease. Tissue Antigens 59, 70-72 (2001).
35. + T cells and macrophages but no crypt-cell hyperplasia. Scand J. Immunol. 38, 581-590 (1993).
36. Lundin, K. E. A. et al. Gliadin-specific, HLA-DQ(α1* 0501,β1*0201)-restricted T cells isolated from the small intestinal mucosa of celiac-disease patients. J. Exp. Med. 178, 187-196 (1993). This study shows that coeliac-disease patients have gluten-specific T cells in their small-intestine mucosa, and that these T cells are restricted by the disease-associated HLA-DQ2 heterodimer.
37. Lundin, K. E. A., Scott, H., Fausa, O., Thorsby, E. & Sollid, L. M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac-disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol. 41, 285-291 (1994).
38. Johansen, B. H., Vartdal, F., Eriksen, J. A., Thorsby, E. & Sollid, L. M. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8, 177-182 (1996).
39. van de Wal, V., Kooy, V. M. C., Drijfhout, J. W., Amons, R. & Koning, F. Peptide-binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule. Immunogenetics 44, 246-253 (1996).
40. Vartdal, F. et al. The peptide-binding motif of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule. Eur. J. Immunol. 26, 2764-2772 (1996).
41. Godkin, A. et al. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ3.2). Int. Immunol. 9, 905-911 (1997).
42. Kwok, W. W., Domeier, M. L., Raymond, F. C., Byers, P. & Nepom, G. T. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156, 2171-2177 (1996).
43. Lee, K. H., Wucherpfennig, K. W. & Wiley, D. C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nature Immunol. 2, 501-507 (2001).
44. Sjöström, H. et al. Identification of a gliadin T-cell epitope in ooeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48, 111-115 (1998). The first paper to show the importance of gluten deamidation for T-cell recognition. The paper reports the first HLA-DQ2-restricted epitope of γ-gliadin.
45. Molberg, Ø. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells. Nature Mad. 4, 713-717 (1998). The first demonstration that the deamidation of glutamine residues in gliadin epitopes is mediated by TG2.
46. Molberg, Ø. et al. T cells from celiac-disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur. J. Immunol. 31, 1317-1323 (2001).
47. van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T-cell reactivity. J. Immunol. 161, 1585-1588 (1998).
48. Fleckenstein, B. et al. Gliadin T-cell epitope selection by tissue transglutaminase in celiac disease: role of enzyme specificity and pH influence on the transamidation vs deamidation reactions. J. Biol. Chem. July 1 2002 (DOI 10.1074/jbc. M204521200) This paper shows that TG2 is involved in the selection of T-cell epitopes in gliadins, characterizes the specificity of TG2 and shows that its propensity for the deamidation reaction is stronger at a slightly acidic pH.
49. Bruce, S. E., Bjarnason, I. & Peters, T. J. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci. 68, 573-579 (1985).
50. Evans, D. F. et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29, 1035-1041 (1988).
51. Sollid, L. M., Molberg, Ø., McAdam, S. & Lundin, K. E. A. Autoantibodies in coeliac disease: tissue transglutaminase - guilt by association? Gut 41, 851-852 (1997).
52. Murtaugh, M. P., Arend, W. P. & Davies, P. J. Induction of tissue transglutaminase in human peripheral-blood monocytes. J. Exp Med. 159, 114-125 (1984).
53. Akimov, S. S., Krylov, D., Reischman, L. F. & Belkin, A. M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 148, 825-838 (2000).
54. Akimov, S. S. & Belkin, A. M. Cell-surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98, 1567-1576 (2001).
55. Le Naour, F. et al. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 276, 17920-17931 (2001).
56. Piper, J. L., Gray, G. M. & Khosla, C. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41, 386-393 (2002).
57. H0 profile dominated by interferon-γ. Gut 37, 766-776 (1995).
58. Nilsen, E. M. et al. Gluten induces an intestinal cytokine response strongly dominated by interferon-γ in patients with celiac disease. Gastroenterology 115, 551-563 (1998).
59. Salvati, V. M. et al. Interleukin-18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 50, 186-190 (2002).
60. Monteleone, G. et al. Role of interferon-α in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425-429 (2001).
61. Bardella, M. T., Marino, R. & Meroni, P. L. Celiac disease during interferon treatment. Ann. Intern. Med. 131, 157-158 (1999).
62. Cammarota, G., Cuoco, L., Cianci, R., Pandolfi, F. & Gasbamini, G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 356, 1494-1495 (2000).
63. Monteleone, G., Pender, S. L., Wathen, N. C. & MacDonad, T. T. Interferon-α drives T-cell-mediated immunopathology in the intestine. Eur. J. Immunol. 31, 2247-2255 (2001).
64. Cerf-Bensussan, N., Cuénod-Jabri, B. & Guy-Grand, D. in Coeliac Disease (eds Mäki, M., Collin, P. & Visakorpi, J. K.) 291-309 (Coeliac Disease Study Group, Tampere, 1997).
65. Pender, S. L. et al. A major role for matrix metalloproteinases in T-cell injury in the gut. J. Immunol. 158, 1582-1590 (1997).
66. Deem, R. L., Shanahan, F. & Targan, S. R. Triggered human mucosal T cells release tumour necrosis factor-α and interferon-γ which kill human colonic epithelial cells. Clin. Exp. Immunol. 83, 79-84 (1991).
67. Maiuri, L. et al. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. Gastroenterology 110, 1368-1378 (1996).
68. van de Wal, Y. et al. Small intestinal T cells of celiac-disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad. Sci. USA 95, 10050-10054 (1998). This paper reports the identification of the first HLA-DQ8-restricted epitope of α-gliadin.
69. van de Wal, Y. et al. Glutenin is involved in the gluten-driven mucosal T-cell response. Eur. J. Immunol. 29, 3133-3139 (1999).
70. Arentz-Hansen, H. et al. The intestinal T-cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med 191, 603-612 (2000). This paper characterizes two immunodominant epitopes of α-gliadin that bind to DQ2 and that are recognized by mucosal T cells of almost all adult coeliac-disease patients. The epitopes overlap and deamidation of a single glutamine residue by TG2 is crucial for T-cell recognition, which indicates a role for TG2 in epitope selection.
71. Anderson, R. P., Degano, P., Godkin, A. J., Jewell, D. P. & Hill, A. V. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nature Med 6, 337-342 (2000). This paper identifies a peptide containing the same two epitopes that are described in reference 70. The T cells that recognize this peptide were found in the peripheral blood after short-term antigenic challenge.
72. Vader, W. et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122, 1729-1737 (2002).
73. Arentz-Hansen, H. et al. Celiac-lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology (in the press).
74. Vanhoof, G., Goossens, F., De Meester, I., Handriks, D. & Scharpe, S. Proline motifs in peptides and their biological processing. FASEB J. 9, 736-744 (1995).
75. Cunningham, D. F. & O'Connor, B. Proline-specific peptidases. Biochim. Biophys. Acta 1343, 160-186 (1997).
76. Hausch, F., Santiago, N. A., Gray, G. M. & Khosla, C. Digestive resistance of immunodominant gliadin peptides: implications for enzyme therapy in celiac sprue. Am. J. Physiol. Gastroenterol. Liver Physiol. June 5 2002 (DOI 10.1152/ajpgi.00136.2002).
77. Nelson, C. A., Vidavsky, I., Viner, N. J., Gross, M. L. & Unanue, E. R. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 94, 628-633 (1997).
78. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. & Rammensee, H. G. Pool sequencing of natural HLA-DR, -DQ and -DP ligands reveals detailed peptide motifs, constraints of processing and general rules. Immunogenetics 39, 230-242 (1994).
79. Vader, L. W. et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195, 643-649 (2002). This study determines the specificity of TG2 by elegant use of gliadin-peptide libraries and mass spectrometry.
80. Rötschke, O., Falk, K. & Strominger, J. L. Superactivation of an immune response triggered by oligomerized T-cell epitopes. Proc. Natl Acad. Sci. USA 94, 14642-14647 (1997).
81. Jardetzky, T. S. et al. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline-II-like conformation for bound peptides. Proc. Natl Acad. Sci. USA 93, 734-738 (1996).
82. Quarsten, H., Molberg, Ø., Fugger, L., McAdam, S. N. & Sollid, L. M. HLA binding and T-cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur. J. Immunol. 29, 2506-2514 (1999).
83. Weiner, H. L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18, 335-343 (1997).
84. Brandtzaeg, P. E. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann. NY Acad. Sci. 964, 13-45 (2002).
85. Haroon, Z. A., Hettasch, J. M., Lai, T. S., Dewhirst, M. W. & Greenberg, C. S. Tissue transglutaminase is expressed, active and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 13, 1787-1795 (1999).
86. Ikura, K., Shinagawa, R., Suto, N. & Sasaki, R. Increase caused by interleukin-6 in promoter activity of guinea-pig liver transglutaminase gene. Biosci. Biotechnol. Biochem. 58, 1540-1541 (1994).
87. Kuncio, G. S. et al. TNF-α modulates expression of the tissue transglutaminase gene in liver cells. Am. J. Physiol. 274, G240-G245 (1998).
88. Williamson, E., Westrich, G. M. & Viney, J. L. Modulating dendritic cells to optimize mucosal immunization protocols. J. Immunol. 163, 366-3675 (1999).
89. Nagler-Anderson, C. Man the barrier! Strategic defences in the intestinal mucosa. Nature Rev. Immunol. 1, 59-67 (2001).
90. Persson, L. A., Ivarsson, A. & Hernell, O. Breast-feeding protects against celiac disease in childhood - epidemiological evidence. Adv. Exp. Med. Biol. 503,115-123 (2002).
91. Doyle, H. A. & Mamula, M. J. Post-translational protein medications in antigen recognition and autoimmunity. Trends Immunol. 22, 443-449 (2001).
92. Girbal-Neuhauser, E. et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 162, 585-594 (1999)
93. Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 101, 273-281 (1998).
94. Masson-Bessiere, C. et al. The major synovial targets of the rheumatoid arthritis-specific antiflaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin. J. Immunol. 166, 4177-4184 (2001).
95. Mamula, M. J. et al. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J. Biol. Chem. 214, 22321-22327 (1999).
96. k-restricted hen egg lysozyme epitope: critical role for asparagine deamidation. J. Exp. Med. 193, 1239-1246 (2001).
97. Gjertsen, H. A., Sollid, L. M., Ek, J., Thorsby, E. & Lundin, K. E. A. T cells from the peripheral blood of celiac-disease patients recognize gluten antigens when presented by HLA-DR, -DQ or -DP molecules. Scand. J. Immunol. 39, 567-574 (1994).
98. Aeschlimann, D. & Paulsson, M. Transglutaminases: protein cross-linking enzymes in tissues and body fuids. Thromb. Haemost. 71, 402-415 (1994).
99. Appel, H., Seth, N. P., Gauthier, L. & Wucherpfennig, K. W. Anergy induction by dimeric TCR ligands. J. Immunol. 166, 5279-5285 (2001).
100. Sette, A., Wentworth, P. & Grey, H. M. Major histocompatibility complex binding peptides: a target for therapeutic development. Curr. Opin. Biotechnol. 2, 877-881 (1991).
101. Folk, J. E. Mechanism and basis for specificity of transglutaminase-catalyzed ε-(γ-glutamyl) lysine bond formation. Adv. Enzymol. Relat. Areas Mol. Biol. 54, 1-56 (1983).